A
AVIR
Atea Pharmaceuticals, Inc.
4.420
+0.180+4.25%After Hours: 4.420 0.000 0.00%16:04 05/22 EDT
OPEN/PREV CLOSE4.280/4.240
TODAY RANGE4.260-4.440
VOL357.71K
MARKET CAP353.72M
52 WEEK RANGE2.710-6.45
AVG VOL (3M)444.79K
% TURNOVER0.45%
TURNOVER--
P/E (TTM)-2.0812
% RANGE4.25%
EPS(TTM)-2.1238
P/E(FORWARD)-2.6788
P/B1.513
BVPS2.920
DIVIDEND--
P/S0.8414
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP306.32M
SHARES OUTSTANDING80.03M
NEXT EARNINGS08/05-08/10
FREE FLOAT69.30M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
Simply Wall St·05/14 10:37
We Think Atea Pharmaceuticals (NASDAQ:AVIR) Needs To Drive Business Growth Carefully
TipRanks·05/14 00:31
Atea Pharmaceuticals Sets Up Catalyst-Rich 2026 Earnings Call
Benzinga·05/12 21:17
Atea Pharmaceuticals Q1 2026 Earnings Call: Complete Transcript
Reuters·05/12 21:04
BRIEF-Atea Pharmaceuticals Reports First Quarter 2026 Financial Results
Reuters·05/12 20:27
Atea Pharmaceuticals Q1 net loss widens on higher R&D spending
Seeking Alpha·05/12 20:21
Atea Pharmaceuticals GAAP EPS of -$0.57 beats by $0.02
Reuters·05/12 20:17
ATEA PHARMACEUTICALS Q1 OPERATING EXPENSES USD 48.008 MILLION
Reuters·05/12 20:17
ATEA PHARMACEUTICALS Q1 EPS USD -0.57